• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三阴性乳腺癌中一种预后性铁死亡相关基因模型的开发与验证

Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer.

作者信息

Wu Song, Pan Ruilin, Lu Jibu, Wu Xiaoling, Xie Jingdong, Tang Hailin, Li Xing

机构信息

State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.

Department of Breast Surgery, The First People's Hospital of Foshan, Foshan, China.

出版信息

Front Oncol. 2022 Jun 2;12:896927. doi: 10.3389/fonc.2022.896927. eCollection 2022.

DOI:10.3389/fonc.2022.896927
PMID:35719954
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9202593/
Abstract

Triple-negative breast cancer (TNBC) is the subtype with the worst prognosis of breast cancer. Ferroptosis, a novel iron-dependent programmed cell death, has an increasingly important role in tumorigenesis and development. However, there is still a lack of research on the relationship between ferroptosis-related genes and the prognosis of TNBC. In this study, we obtained the gene expression profile of TNBC patients and matched clinical data from The Cancer Genome Atlas (TCGA) database. Univariate Cox analysis was used to screen out ferroptosis-related genes associated with TNBC prognosis. Then, the least absolute shrinkage and selection operator (LASSO) regression analysis was employed to establish a prognostic prediction model. A 15-ferroptosis-related gene prognostic prediction model was developed, which classified patients into low-risk (LR) or high-risk (HR) groups. Kaplan-Meier analysis results showed that the prognosis of the LR group was better. The receiver operating characteristic (ROC) curve also confirmed the satisfactory predictive ability of this model. Evaluation of the immune microenvironment of TNBC patients in the HR and LR group suggested these 15 ferroptosis-related genes might affect the prognosis of TNBC by regulating the tumor microenvironment. Our prognostic model can provide a theoretical basis for accurate prognosis prediction of TNBC in clinical practice.

摘要

三阴性乳腺癌(TNBC)是乳腺癌预后最差的亚型。铁死亡是一种新型的铁依赖性程序性细胞死亡,在肿瘤发生发展中发挥着越来越重要的作用。然而,关于铁死亡相关基因与TNBC预后之间的关系仍缺乏研究。在本研究中,我们从癌症基因组图谱(TCGA)数据库中获取了TNBC患者的基因表达谱及匹配的临床数据。采用单因素Cox分析筛选出与TNBC预后相关的铁死亡相关基因。然后,运用最小绝对收缩和选择算子(LASSO)回归分析建立预后预测模型。构建了一个包含15个铁死亡相关基因的预后预测模型,该模型将患者分为低风险(LR)组或高风险(HR)组。Kaplan-Meier分析结果显示,LR组的预后较好。受试者工作特征(ROC)曲线也证实了该模型具有令人满意的预测能力。对HR组和LR组TNBC患者免疫微环境的评估表明,这15个铁死亡相关基因可能通过调节肿瘤微环境影响TNBC的预后。我们的预后模型可为临床实践中TNBC的准确预后预测提供理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7234/9202593/ae91615b1851/fonc-12-896927-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7234/9202593/49c5260e8db0/fonc-12-896927-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7234/9202593/3773d1171675/fonc-12-896927-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7234/9202593/14416d266134/fonc-12-896927-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7234/9202593/e03821eade36/fonc-12-896927-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7234/9202593/ae91615b1851/fonc-12-896927-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7234/9202593/49c5260e8db0/fonc-12-896927-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7234/9202593/3773d1171675/fonc-12-896927-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7234/9202593/14416d266134/fonc-12-896927-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7234/9202593/e03821eade36/fonc-12-896927-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7234/9202593/ae91615b1851/fonc-12-896927-g005.jpg

相似文献

1
Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer.三阴性乳腺癌中一种预后性铁死亡相关基因模型的开发与验证
Front Oncol. 2022 Jun 2;12:896927. doi: 10.3389/fonc.2022.896927. eCollection 2022.
2
An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer.铁代谢和免疫相关基因特征可预测三阴性乳腺癌的临床结局和分子特征。
BMC Cancer. 2022 Jun 7;22(1):619. doi: 10.1186/s12885-022-09679-x.
3
Establishment of a prognostic ferroptosis-related gene profile in acute myeloid leukaemia.建立急性髓系白血病预后相关的铁死亡基因特征。
J Cell Mol Med. 2021 Dec;25(23):10950-10960. doi: 10.1111/jcmm.17013. Epub 2021 Nov 5.
4
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.鉴定铁死亡相关基因特征在乳腺癌患者中的预后价值。
BMC Cancer. 2021 May 31;21(1):645. doi: 10.1186/s12885-021-08341-2.
5
Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression of triple‑negative breast cancer.鉴定TFR2作为一种新型铁死亡相关基因,其在三阴性乳腺癌的预后和进展中起重要作用。
Oncol Lett. 2023 Dec 5;27(2):43. doi: 10.3892/ol.2023.14176. eCollection 2024 Feb.
6
Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes.基于自噬相关基因的三阴性乳腺癌预后风险模型的构建与验证
Front Oncol. 2022 Feb 4;12:829045. doi: 10.3389/fonc.2022.829045. eCollection 2022.
7
Upregulation of the ferroptosis-related gene is a specific predictor of poor triple-negative breast cancer patient outcomes.铁死亡相关基因的上调是三阴性乳腺癌患者预后不良的特异性预测指标。
Front Oncol. 2023 Mar 31;13:1032364. doi: 10.3389/fonc.2023.1032364. eCollection 2023.
8
Ferroptosis and triple-negative breast cancer: Potential therapeutic targets.铁死亡与三阴性乳腺癌:潜在的治疗靶点。
Front Oncol. 2022 Dec 9;12:1017041. doi: 10.3389/fonc.2022.1017041. eCollection 2022.
9
Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer.鉴定和验证一种新型糖酵解相关基因签名,用于预测三阴性乳腺癌的预后和治疗反应。
Adv Ther. 2023 Jan;40(1):310-330. doi: 10.1007/s12325-022-02330-y. Epub 2022 Nov 1.
10
A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer.一种与肿瘤微环境相关的新型模型预测三阴性乳腺癌的预后和免疫治疗。
Clin Exp Med. 2023 Nov;23(7):3867-3881. doi: 10.1007/s10238-023-01090-5. Epub 2023 May 23.

引用本文的文献

1
Identification of Molecular Subtypes and Prognostic Features for Triple-Negative Breast Cancer Based on Golgi Apparatus-Related Gene Signature.基于高尔基体相关基因特征的三阴性乳腺癌分子亚型及预后特征鉴定
Oncol Res. 2025 Jul 18;33(8):2013-2035. doi: 10.32604/or.2025.061757. eCollection 2025.
2
Ferritinophagy in cardiovascular diseases: mechanisms and potential therapy.心血管疾病中的铁蛋白自噬:机制与潜在治疗方法
Mol Cell Biochem. 2025 Jun 20. doi: 10.1007/s11010-025-05301-3.
3
Penicilazaphilone C triggers ferroptosis in triple-negative breast cancer cells via the MDM2/p53/SLC7 A11/GPX4 pathway.

本文引用的文献

1
Recent Progress of Ferroptosis in Lung Diseases.铁死亡在肺部疾病中的研究进展
Front Cell Dev Biol. 2021 Nov 16;9:789517. doi: 10.3389/fcell.2021.789517. eCollection 2021.
2
The Role of Iron in Cancer Progression.铁在癌症进展中的作用。
Front Oncol. 2021 Nov 10;11:778492. doi: 10.3389/fonc.2021.778492. eCollection 2021.
3
CircAKT3 promotes cell proliferation, survival and glutamine metabolism of gastric cancer by activating SLC1A5 expression via targeting miR-515-5p.环状 AKT3 通过靶向 miR-515-5p 促进 SLC1A5 表达,从而促进胃癌细胞增殖、存活和谷氨酰胺代谢。
青霉氮杂菲酮C通过MDM2/p53/SLC7A11/GPX4途径在三阴性乳腺癌细胞中引发铁死亡。
Discov Oncol. 2025 Jun 2;16(1):983. doi: 10.1007/s12672-025-02687-w.
4
Current Status and Future Directions of Ferroptosis Research in Breast Cancer: Bibliometric Analysis.乳腺癌中铁死亡研究的现状与未来方向:文献计量分析
Interact J Med Res. 2025 Feb 26;14:e66286. doi: 10.2196/66286.
5
Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application.靶向起始因子以激活铁死亡和铜死亡用于乳腺癌治疗:临床应用的进展与可能性
Front Pharmacol. 2025 Jan 10;15:1493188. doi: 10.3389/fphar.2024.1493188. eCollection 2024.
6
Targeting Hepatocellular Carcinoma: Schisandrin A Triggers Mitochondrial Disruption and Ferroptosis.靶向肝细胞癌:五味子醇甲引发线粒体破坏和铁死亡。
Chem Biol Drug Des. 2024 Dec;104(6):e70010. doi: 10.1111/cbdd.70010.
7
Interactions between ferroptosis and tumour development mechanisms: Implications for gynaecological cancer therapy (Review).铁死亡与肿瘤发生机制之间的相互作用:对妇科癌症治疗的启示(综述)
Oncol Rep. 2025 Feb;53(2). doi: 10.3892/or.2024.8851. Epub 2024 Dec 5.
8
Identification and validation of mRNA profiles linked to ATP- induced cell death represent a novel prognostic model for breast cancer.鉴定和验证与 ATP 诱导细胞死亡相关的 mRNA 谱代表了一种新的乳腺癌预后模型。
Front Immunol. 2024 Nov 1;15:1483498. doi: 10.3389/fimmu.2024.1483498. eCollection 2024.
9
SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.SOX13 是一种新型预后生物标志物,与乳腺癌的免疫浸润相关。
Front Immunol. 2024 Apr 19;15:1369892. doi: 10.3389/fimmu.2024.1369892. eCollection 2024.
10
Construction and experimental validation of a novel ferroptosis-related gene signature for myelodysplastic syndromes.构建并验证一个用于骨髓增生异常综合征的新型铁死亡相关基因特征。
Immun Inflamm Dis. 2024 Apr;12(4):e1221. doi: 10.1002/iid3.1221.
Histol Histopathol. 2022 Mar;37(3):227-241. doi: 10.14670/HH-18-401. Epub 2021 Dec 1.
4
Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance.聚(ADP-核糖)聚合酶在三阴性乳腺癌中的作用:抑制机制、临床应用及耐药性
Biomedicines. 2021 Oct 21;9(11):1512. doi: 10.3390/biomedicines9111512.
5
Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients.基于免疫评分的铁死亡相关基因作为肝细胞癌患者预后标志物的鉴定与验证
J Gastrointest Oncol. 2021 Oct;12(5):2345-2360. doi: 10.21037/jgo-21-237.
6
Treatment landscape of triple-negative breast cancer - expanded options, evolving needs.三阴性乳腺癌的治疗现状——选择增多,需求变化。
Nat Rev Clin Oncol. 2022 Feb;19(2):91-113. doi: 10.1038/s41571-021-00565-2. Epub 2021 Nov 9.
7
Establishment of a prognostic ferroptosis-related gene profile in acute myeloid leukaemia.建立急性髓系白血病预后相关的铁死亡基因特征。
J Cell Mol Med. 2021 Dec;25(23):10950-10960. doi: 10.1111/jcmm.17013. Epub 2021 Nov 5.
8
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges.致癌性 KRAS 阻断治疗:重燃热情与持续挑战。
Mol Cancer. 2021 Oct 4;20(1):128. doi: 10.1186/s12943-021-01422-7.
9
Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs.三阴性乳腺癌:尽管取得了一些成果,但仍有一座有待攀登的山峰。
Cancers (Basel). 2021 Jul 23;13(15):3697. doi: 10.3390/cancers13153697.
10
Glycyrrhetinic acid induces oxidative/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and depriving glutathione in triple-negative breast cancer cells.甘草次酸通过激活 NADPH 氧化酶和诱导型一氧化氮合酶,以及耗尽三阴性乳腺癌细胞中的谷胱甘肽,诱导氧化/硝化应激并引发铁死亡。
Free Radic Biol Med. 2021 Sep;173:41-51. doi: 10.1016/j.freeradbiomed.2021.07.019. Epub 2021 Jul 14.